Robert M. Pascuzzi - Concepedia

Author

Robert M. Pascuzzi

Indiana University – Purdue University Indianapolis ORCID

Also Known As

Amanda Anderson, Christine Banda, Daniel Newman, John Kissel, R M Pascuzzi, R PASCUZZI, R Pascuzzi, R. M. Pascuzzi, R. Pascuzzi, R.M. Pascuzzi

164

Publications

7.7K

Citations

H-Index

129

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine University of Kansas Medical Center George Washington University University Medical Center

About

Robert M. Pascuzzi is an author at Indiana University – Purdue University Indianapolis specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	26	2.1K
2	Health Sciences	5	5	202
3	Social Sciences	5	5	113
4	Public Health	2	2	166
5	Nursing	1	1	12

Robert M. Pascuzzi

Publications

Citations

H-Index

Page 1

	Year	Citations
Randomized Trial of Thymectomy in Myasthenia Gravis Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, New England Journal of Medicine	2016	873
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study James F. Howard, Kimiaki Utsugisawa, Michael Benatar, The Lancet Neurology Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade	2017	745
Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1 William J. Groh, Miriam R. Groh, Chandan Saha, New England Journal of Medicine	2008	504
Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 Patients Robert M. Pascuzzi, H. Branch Coslett, T. R. Johns Annals of Neurology	1984	330
Occurrence of amyotrophic lateral sclerosis among Gulf War veterans Ronnie D. Horner, Steven C. Grambow, Jennifer Hoff-Lindquist, Neurology	2003	262
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study Vera Bril, Artur Drużdż, Julian Großkreutz, The Lancet Neurology Clinical TrialsGeneralised Myasthenia GravisPharmacotherapyMedicineAnesthesiology	2023	227
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, The Lancet Neurology	2019	216
A Genome-Wide Association Study of Myasthenia Gravis Alan E. Renton, Hannah A. Pliner, Carlo Provenzano, JAMA Neurology	2015	214
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study James F. Howard, Saskia Bresch, Angela Genge, The Lancet Neurology MedicineSurgeryClinical TrialsGeneralised Myasthenia Gravis	2023	213
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis Merit Cudkowicz, Jeremy M. Shefner, David Schoenfeld, Neurology	2003	203

Page 1